National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1415864

Case Details

VAERS ID: 1415864 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain upper, Maternal exposure during pregnancy, Syncope, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness: Pregnancy
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation; Immunodeficiency; Ulcerative colitis
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021657299

Write-up: Faint; Vomited; Stomach cramps; patient was exposed to the medicine second-trimester (13-28 weeks); This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106051020264080-I3EW9 and Safety Report Unique Identifier GB-MHRA-ADR 25425444. A 34-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTtech COVID-19 VACCINE), via an unspecified route of administration on 04Jun2021 (Batch/Lot number: Unknown), at the age of 34 years, as 1st dose, single for COVID-19 immunization. Medical history included ulcerative colitis, ongoing pregnancy, immunodeficiency and folic acid supplementation. Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. Concomitant medications included folic acid taken for folic acid supplementation. On 05Jun2021, the patient experienced faint, vomited and stomach cramps. On 04Jun2021, the patient was exposed to the medicine second-trimester (13-28 weeks). Patient has not tested positive for COVID-19 since having the vaccine. The case is serious (medically significant). The outcome of the event faint was recovered on an unspecified date; events stomach cramps and vomited outcome was recovering. The outcome for patient was exposed to the medicine second-trimester (13-28 weeks) was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166